| Identification | Back Directory | [Name]
3β-[(3-O-Methyl-2,6-dideoxy-β-D-xylo-hexopyranosyl)oxy]-11α,14-dihydroxy-5β-card-20(22)-enolide | [CAS]
98633-61-5 | [Synonyms]
Sarmentocymarin
3β-[(3-O-Methyl-2,6-dideoxy-β-D-xylo-hexopyranosyl)oxy]-11α,14-dihydroxy-5β-card-20(22)-enolide
3β-[(3-O-Methyl-2,6-dideoxy-β-D-xylo-hexopyranosyl)oxy]-11α,14-dihydroxy-5β-card-20(22)-enolide
11α,14-dihydroxy-3β-(O3-methyl-β-D-xylo-2,6-dideoxy-hexopyranosyloxy)-5β,14β-card-20(22)-enolide
Card-20(22)-enolide, 3-[(2,6-dideoxy-3-O-methyl-β-D-xylo-hexopyranosyl)oxy]-11,14-dihydroxy-, (3β,5β,11α)- | [Molecular Formula]
C30H46O8 | [MOL File]
98633-61-5.mol | [Molecular Weight]
534.69 |
| Hazard Information | Back Directory | [Uses]
Sarmentocymarin can be isolated from the air-dried powd. roots of Cryptolepis buchanani Roem[1]. | [References]
[1] Chen K K, et al. The potency of five additional cardiac glucosides, calotropin,?偽-antiarin, emicymarin, folinerin and sarmentocymarin[J]. The Journal of the American Pharmaceutical Association (1912), 1937, 26(3): 214-218. |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|